Please login to the form below
Dr Michael Mehler joins leon-nanodrugs as CEO
He succeeds Dr Ted Odlaug
Munich-headquartered leon-nanodrugs has appointed Dr Michael Mehler as chief executive officer, succeeding Dr Ted Odlaug who moves to the supervisory board.
Dr Mehler brings over 25 years of leadership experience in the pharma and biotech industries, most recently as chief executive of SpePharm, a Switz specialty hospital products developer.
Prior to this, he was chief executive officer of Riemser Pharma, and held a number of positions at Actelion Pharmaceuticals, Merck & Co and Novartis.
Dr Hubert Birner, chairman of the leon-nanodrugs board, said: “We welcome Michael to lead leon nanodrugs on our joint journey to continued growth and internationalisation.
“We know Michael as a very experienced executive and look forward to working with him.
“We would also like to express our sincere appreciation to Ted who did a tremendously impressing job - he will obviously bring his valuable expertise to the board in his new role and continue to complement our management team.”
Featured jobs
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
Subscribe to our email news alerts
- Boehringer taps Korea’s Bridge for Ofev follow-up
- Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
- Novartis and J&J back latest €400m Medicxi biopharma fund
- How To Get To A Great Culture by Dave Birss
- Episode 2: Alder Play - Cameron Day (ustwo)
- Episode 1: Patient Centricity on Trial - Claire Knapp and Mark Evans, Havas Lynx Group, Keynote
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
